The study is designed to evaluate the safety of performing the new tissue containment system during laparoscopic myomectomy morcellation. Pre- and perimenopausal women, aged 18-45 undergoing laparoscopic myomectomy morcellation

Inclusion Criteria:

• Pre- and Peri-menopausal woman patient age 18-45 years

  • Women with fibroids and indication for laparoscopic myomectomy.
  • Normal Pap smear result within one year
  • MRI ( Magnatic Resonance Imaging ) or other imaging findings indicate the diameter of the largest uterine fibroids is between 4 to 10cm.
  • The body mass index of the patients is 18.5-27.9kg/m2
  • Signed informed consent form

Exclusion Criteria:

• • Women with Known or suspected malignancy

  • patients with severe pelvic adhesion found during the operation
  • The body mass index of the patient ≥ 28kg/m2
  • Diameter of a single uterine fibroid>10cm
  • patients during pregnancy and lactation
  • Known blood diseases, bleeding coagulation disease, any part of the active bleeding or bleeding tendency of the constitution of the patient
  • Patients with known severe liver and kidney dysfunction;Liver function (ALT, AST) ≥ 2 times of normal upper limit, or renal function (Cr) ≥ normal upper limit
  • Patients who are known to have participated in any other clinical trial within 3 months
  • Patients who cannot sign informed consent
  • Patients with acute stage infection of the reproductive system or other sites

IPD will to be shared with other researchers after four years